Ryan Tabis, PharmD, received his Doctor of Pharmacy Degree from the University of Arizona College of Pharmacy in 2006. He then completed a PGY-1 residency at the University of Tennessee Medical Center followed by a PGY-2 Specialty Residency in Internal Medicine at the Phoenix VA Healthcare System.
Currently, Tabis is an assistant professor in the Division of Practice Advancement and Clinical Education. His primary practice site is at WakeMed Health & Hospitals in Raleigh, where he serves as clinical pharmacist specialist in Internal Medicine & Surgery. In addition, Tabis is the program director for the PGY-1 Pharmacy Practice Residency at WakeMed.
Tabis has been board-certified in pharmacotherapy since 2009. He is involved with several professional organizations, including the ASHP Section Advisory Group on Emerging Sciences.
Practice Site: WakeMed Health & Hospitals
Gastrointestinal Diseases, Antimicrobial Stewardship, Pharmacy Informatics
- Sparks ER*, Holt S, Tabis R. “Evaluation of various dosing strategies for rifaximin in the treatment of hepatic encephalopathy.” Poster presented at ASHP Midyear Meeting, December 2014
- Coleman H*, Gregory P, Tabis R. “Exploring the current roles and responsibilities of pharmacists within primary care settings in the United States.” Poster presented at ASHP Midyear Meeting, December 2014
- McNaull M*, Holt S, Tabis R. “Pharmacotherapy optimization bundle in hospitalized patients with active Clostridium difficile infections.” Poster presented at ASHP Midyear Meeting, December 2014
- Kim, J*, Tabis R. “Optimization of vancomycin q8 hour dosing in young adults: Comparision of nomogram versus population pharmacokinetic-based dosing.” Poster presented at Research Triangle Park Biosciences and Biotechnology Conference, May 2014
- Eibling A*, Tabis R. “Difference in C. difficile severity scores in predicting non-response to metronidazole.” Poster presented at ASHP Midyear Meeting, December 2013
- Shah P*, Tabis R, Benner A, Terbet L. “Differences in response rate to metronidazole or vancomycin in patients with hospital-acquired C. difficile infection.” Poster presented at ASHP Midyear Meeting, December 2012
- Girardeau C*, Ingram C, Tabis R, Kelly K. “Implementation of a multi-disciplinary antimicrobial stewardship program in a community hospital.” Poster presented at ASHP Midyear Meeting, December 2010
- Nov 2013 – “Treatment of Hepatitis C: The Future is Bright!” Presented at Triangle College of Clinical Pharmacy Meeting, Chapel Hill, NC
- June 2012 – “Implementation of Theradoc® to Improve Antimicrobial Stewardship Efficiency: One Institution’s Experience.” Presented as webinar in “Pharmacist Brown Bag” series
- Oct 2011 – “New Antimicrobial Agents 2011.” Presented at North Carolina Association of Pharmacists (NCAP) Fall meeting, Greensboro, NC
- Doctor of Pharmacy, University of Arizona College of Pharmacy, 2002-2006
- PGY-1 Pharmacy Practice Residency, University of Tennessee Medical Center, 2006-2007
- PGY-2 Specialty Residency in Internal Medicine, Phoenix VA Healthcare System, 2007-2008
- Board Certified Pharmacotherapy Specialist